












The cardiovascular system is the first organ system to develop in
vertebrate embryos. In the mouse, mesoderm-derived cardiac
progenitors coalesce at the midline to give rise to a linear heart tube
that begins to beat by early day 8 (Harvey et al., 1999; Ji et al., 2003;
Tam and Schoenwolf, 1999). Concurrent with heart formation,
blood and vessels first form in the extraembryonic yolk sac. By 8.5
days post-coitum (dpc), a capillary plexus consisting of a polygonal
network of endothelial-lined channels is evident in the yolk sac and
these vessels ultimately connect to the embryo, completing a
circulatory loop between embryonic and extra-embryonic tissues.
Once the heart begins to beat, primitive erythroblasts originating in
the yolk sac can be found in the embryo by 4- to 6-somites (Ji et al.,
2003; McGrath et al., 2003). Between 8.5 and 9.5 dpc, primitive
vessels of the yolk sac undergo remodeling in the presence of flow
to form a branched, hierarchical network of large and small-caliber
vessels surrounded by smooth muscle cells (for a review, see
Armulik et al., 2005).
The normal development of the cardiovascular system depends
on a large number of genes, suggesting complex signaling pathways
(Argraves and Drake, 2005; Solloway and Harvey, 2003; Trinh and
Stainier, 2004). In fact, just one aspect of development – vascular
remodeling in the murine yolk sac – requires over 60 known genes
(our unpublished observations), including members of the Tgf-,
Notch, Vegf, hedgehog and retinoic acid signaling pathways.
Although many genes required for proper vascular remodeling are
expressed in endothelial cells and are thought to play a role in these
cells directly, mutations in many genes required solely for cardiac
function also cause defects in vascular remodeling. For instance, null
mutations in Ncx1 (also known as Slc8a1 – Mouse Genome
Informatics) (Koushik et al., 2001; Wakimoto et al., 2000), myosin
light chain 2a (Mlc2a; also known as Myl7 – Mouse Genome
Informatics) (Huang et al., 2003), Nkx2.5 (Tanaka et al., 1999) and
titin (May et al., 2004) all exhibit failed yolk sac remodeling despite
a lack of expression of these genes in endothelial cells. Furthermore,
vascular abnormalities caused by the deletion of N-cadherin
(cadherin 2) can be rescued by cardiac-specific expression of either
N- or E-cadherin (cadherin 1) (Luo et al., 2001). To explain these
effects, it has been proposed that normal blood flow is necessary for
vascular remodeling. Numerous studies from avian embryos, dating
back to well over a century ago, support this hypothesis because the
surgical manipulation of blood flow can lead to a wide range of
abnormalities in heart and vessel development (Keller, 2001; Kurz,
2000).
Whereas many studies show that blood flow is required for vessel
and cardiac remodeling, what continues to be debated is the reason
why blood flow is important (Conway et al., 2003; Coultas et al.,
2005; Huang et al., 2003; May et al., 2004). For instance, it can be
argued that blood flow is required to deliver oxygen or nutrients to
remodeling tissues. Hypoxic conditions could damage endothelial
cells directly or alter the levels of necessary growth factors such as
Vegf (also known as Vegfa – Mouse Genome Informatics), which
could impair remodeling (Conway et al., 2003; May et al., 2004).
However, early mouse embryos (8.5 dpc), like early chick (Cirotto
and Arangi, 1989; Pelster and Burggren, 1996; Territo and
Burggren, 1998), frog (Territo and Burggren, 1998) and zebrafish
embryos (Pelster and Burggren, 1996), can be cultured in the
presence of carbon monoxide, which competes for oxygen binding
to hemoglobin, without effecting the initial stages of vasculogenesis
or vascular remodeling (E.A.V.J., S.E.F. and M.E.D., unpublished).
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Another argument is that early blood flow functions to transport
soluble nutrients, such as cell-signaling molecules that are required
for vascular remodeling (Conway et al., 2003), although there is no
direct evidence to support such a mechanism.
A third hypothesis for the role of circulation is that it imparts force
on plexus endothelial cells and this mechanical force is necessary to
activate cell-signaling cascades necessary for vessel remodeling.
Blood flow exerts two types of force on vessels: shear stress, the
frictional force tangential to endothelial cells, and circumferential
strain, a force perpendicular to the direction of flow and which is
related to intravascular pressure. Numerous studies have shown that
cultured endothelial cells can respond to these forces by changing
morphology, activating intracellular kinases and inducing gene
expression (for a review, see Li et al., 2005) and shear stress levels
in the mouse yolk sac are within the range known to induce these
responses in cultured endothelial cells (Jones et al., 2004). Despite
the circumstantial evidence for flow-derived force in vascular
remodeling, no direct evidence exists to show that mechanical
signals drive remodeling during development or to exclude the
possibility that the local oxygen supply or soluble paracrine factors
provided through circulation act as a trigger.
To better understand the role of circulation during early
embryonic mouse development, we have used whole-embryo
culture and time-lapse confocal imaging (Jones et al., 2002) to
visualize and quantify blood flow in early embryos. We first used
these methods to analyze dynamic events at the onset of circulation
in normal mouse embryos. Next, we characterized circulation
deficiencies in Mlc2a-null embryos to understand how secondary
remodeling defects are generated by impaired cardiac contractility.
Finally, we tested whether altering the mechanical properties of the
early blood can phenocopy the vascular remodeling defect seen in
Mlc2a–/– embryos. These studies reveal that erythroblast circulation
begins after a prolonged period of plasma flow, that both plasma and
erythroblast flow are disrupted in Mlc2a mutant embryos, and that
the change in effective viscosity caused by the entry of blood cells
into circulation is required to induce proper remodeling. Thus, using
novel methods to analyze and manipulate blood flow in early mouse
embryos, we have answered a century-old question about the role of
mechanical force in vessel remodeling in vivo.
MATERIALS AND METHODS
Embryo preparation and time-lapse microscopy
Breeding pairs of Mlc2a+/–;Tg(-globin-GFP) mice or Tg(-globin-GFP)
mice (Dyer et al., 2001; Huang et al., 2003) were mated and the presence of
a vaginal plug was taken as 0.5 dpc. Embryos were collected at 8.5 dpc and
cultured for time-lapse microscopy (Jones et al., 2002). To study the
initiation of flow in normal embryos, single images were taken every 6
minutes using a 20 Plan-Neofluar 0.5NA lens on a Zeiss LSM 5 PASCAL.
For tracking erythroblast motion in Mlc2a mutants, images were taken at
two frames/second using a 40C-Apochromat 1.2NA objective. Individual
cells were tracked manually by connecting the center of the same cell in
subsequent images. Overlay of tracking data onto the images was performed
using Adobe Photoshop.
Plasma flow measurements
To determine if plasma could be transported from the embryo to the yolk sac,
0- to 6-somite embryos were dissected as previously described (Jones et al.,
2002). A pulled quartz needle (Sutter Instruments) was filled with 10103
Mr fluorescein-dextran (Molecular Probes, D-1821) and a picospritzer II
(General Valve Corporation) was used to inject nanoliter volumes of dye into
the heart tube. Embryos were allowed to recover for up to 10 minutes at 37°C
and were imaged with the Zeiss LSM PASCAL at 20 magnification to
determination whether plasma was transported to the yolk sac.
For FRAP experiments, embryos at different stages were injected with
10103 Mr fluorescein-dextran (50 mg/ml) and transferred to Nunc
chambers (No. 155380) with culture medium (Jones et al., 2002). Embryos
recovered for 15 minutes to 1 hour at 37°C. The microscope stage (Zeiss
LSM 5 PASCAL or Zeiss LSM 510 META) was preheated to 37°C using a
heater box (Jones et al., 2002). For reproducibility, measurements were
always taken from the same region on the arterial side of the yolk sac near
the caudal end of the embryo. Since the Mlc2a mutants cannot be
unambiguously identified at the 8- to 9-somite stage, all embryos were
measured blind and then genotyped after FRAP experiments. Embryos with
blood cells throughout the plexus were avoided so that the movement of
blood cells did not interfere with plasma measurements. For acrylamide-
treated embryos (see below), acrylamide was polymerized by the addition
of TEMED and embryos were allowed to recover at 37°C for 15-30 minutes
prior to the injection of fluorescein-dextran (see Fig. S1 in the supplementary
material). Using a 20 Plan-Apochromat 0.75 NA lens, image intensity was
recorded within a region of interest (ROI) using 5% laser power. Laser power
was then increased to 100% and the ROI was scanned repeatedly to bleach
the fluorescence. Laser power was then reduced back to 5% to image the
recovery of the dye into the bleached field. Somites were counted following
the measurement.
Mean fluorescence with respect to time for the ROI was exported to a
spreadsheet. The recovery curve was fitted to the equation (Soumpasis,
1983):
where F(t) is the fluorescence intensity, F0 is the initial post-bleach
fluorescence intensity, FF is the final level of fluorescence recovery, I0 and
I1 are zeroth and first order Bessel’s functions, and  is the characteristic
diffusion time. The bleach area was divided by characteristic diffusion time
to give the measured diffusion. The baseline for pure diffusion was obtained
by injecting embryos with fluorescein-dextran as described, stopping the
heart by chilling the embryos at 4°C for 1 hour, reheating the embryos to
37°C and performing FRAP.
Erythroblast immobilization
The blood islands of 5-somite stage Tg(-globin-GFP) embryos were gently
microinjected with a 30% (w/v) solution of acrylamide:bis-acrylamide
(37.5:1; 161-0158, BioRad) diluted 1:1 with 2PBS; ammonium persulfate
(161-0700, BioRad) was added to a final concentration of 10 mM (see
Fig. S1 in the supplementary material). The medium was exchanged and
the embryos recovered for approximately 15 minutes. To catalyze
polymerization of acrylamide, TEMED (161-0801, BioRad) was diluted 1:1
with 2PBS and applied to the blood islands using a micropipette with a
low positive pressure. The tip of the micropipette was gently touched to the
surface of the blood islands at a number of points to initiate gel formation.
The optimal dilutions for both TEMED and acrylamide were determined by
dilution series (data not shown). The medium was subsequently changed and
the embryos placed in roller culture as previously described (Tam, 1998).
Three sets of controls were performed: (1) uninjected embryos; (2) embryos
injected only with the acrylamide solution; and (3) embryos in which only
TEMED was delivered to the blood islands.
To assess embryo development, yolk sac growth and remodeling,
embryos were imaged at the same magnification with a Zeiss Axiocam
mounted on a Zeiss Lumar stereomicroscope equipped for fluorescence
imaging. Texas Red-dextran (Molecular Probes, D-1828) was injected to
better visualize remodeling. The image scale was calibrated to an etched
glass standard and the yolk sac perimeter was traced using Zeiss Axiovision
software. The area of the field within the traced image of the yolk sac was
recorded as the size of the yolk sac. Turning was scored on a scale of 1 to 5
(1, not turned; 3, partially turned; 5, fully turned) and yolk sac vessel
remodeling was scored on a scale of 1 to 5 (1, regular polygonal structure
throughout yolk sac; 3, increased avascular space and lengthening of
vascular segments but no obvious branching pattern; 5, hierarchical
branching pattern present throughout the yolk sac with the appearance of
large-caliber vessels). Embryos were not matched to their experimental








































(SPSS, Chicago, IL). Data were compared using one-way ANOVA with
Bonferroni post-hoc analysis. Statistical significance was determined at a
level of 5% alpha error between experimental groups and control for a single
measure (P<0.05).
Hetastarch injection
Hetastarch (Sigma Aldrich, H2648) consists of a high-molecular-weight
hydroxyethyl starch in a physiologic saline solution (6% in 0.9% NaCl).
Approximately 1-2 hours after TEMED administration, embryos received
an intracardiac injection of hetastarch and were placed in roller culture.
Immunohistochemistry
Embryos were treated as described above to produce control, low-hematocrit
and low-hematocrit+hetastarch groups. After 24 hours in roller culture,
embryos were immediately fixed in 4% paraformaldehyde for 1 hour at 4°C
then transferred to methanol or PBS for storage. Yolk sacs were incubated
overnight at 4°C in one of the following primary antibodies: anti-PECAM-
1 (Pinter et al., 2001), anti-VE-cadherin (R&D Systems, Minneapolis, MN;
1:100), or anti-eNOS (Santa Cruz Biotechnology, Santa Cruz, CA; 1:200).
Alexa Fluor 594 or 568 secondary antibodies (Invitrogen, Carlsbad, CA)
were used depending on the primary species. Images of staining patterns
were collected using a Zeiss 510 META confocal system and a 40 C-
Apochromat 1.2NA objective. All images for a single antibody were
collected using the same laser power and detector gain settings in order to
visually compare the relative intensity levels. Images shown are a maximum
intensity projection of several optical slices. Each image is a representative
sample of the 5-11 embryos that were stained from each group.
RESULTS
Initiation of blood flow in wild-type embryos
Previous studies showed, by examining the location of erythroblasts
in fixed mouse embryos, that erythroblasts enter circulation in a
stepwise pattern beginning at the 4- to 6-somite stage (Ji et al., 2003;
McGrath et al., 2003). To observe the onset of circulation in live
embryos, we imaged the movement of GFP-labeled erythroblasts
using time-lapse confocal microscopy (Jones et al., 2002). Tg(-
globin-eGFP) embryos (n=3) were placed in culture at the 5- to 6-
somite stage (Fig. 1 and see Movie 1 in the supplementary material).
During the first hour, the heart beat was evident but circulating
erythroblasts were not observed (Fig. 1A,H). Occasionally, GFP+
erythroblasts were seen outside the blood islands, but only as single,
adherent, stationary cells (Fig. 1A, red arrow). It is not clear whether
these cells differentiated at these sites or were previously moving but
had stopped. As erythroblasts begin to enter the circulation, the
volume percentage of erythroblasts in vessels (hematocrit) is initially
low and fluctuates from one frame to another (Fig. 1B). Many blood
cells were seen to flow with a net forward motion, but some
individual erythroblasts became stationary and grouped together
(see Movie 1 in the supplementary material). Some groups of
erythroblasts remained adherent to one another for up to 3 hours
(Fig. 1, arrows) before dissociating and then rejoining the
circulation. Thus, intermittent erythroblast motion was detected as
early as the 6- to 7-somite stage and progressively more
erythroblasts became recruited into the circulation over the next few
hours.
The onset of circulation is usually defined by the movement of
erythroblasts, but we were interested in determining whether
significant plasma flow exists prior to erythroblast circulation. In
agreement with previous findings, we detected a beating heart in
embryos as early as the 3-somite stage (Navaratnam et al., 1986). To
test whether the heart could pump plasma from the embryo to the
yolk sac, we injected fluorescent dextran into the hearts of early-
somite stage embryos and examined whether the dextran could be
observed in the yolk sac plexus after a 10-minute recovery period.
In 0- and 1-somite stage embryos, injected dextran remained
confined to the heart (n=4, data not shown). Similarly, dextran did
not distribute in most 2-somite stage embryos (5 of 6 embryos, Fig.
2A,B). However, dextran was found consistently throughout the
capillary plexus including the blood islands in 3-somite and older
embryos (20 of 20 embryos; Fig. 2C,D). Higher magnification views
of 3- and 6-somite (Fig. 2E,F) yolk sacs are shown to illustrate the
distribution of the dextran within the plexus vessels. These results
show that a continuous vessel network between the capillary plexus
is established at least by the time the heart begins to beat.
The rapid distribution of dextran throughout the plexus suggested
that there is significant plasma flow produced by the first heart beats.
To confirm this, we measured plasma flow in embryos prior to the
entry of erythroblasts using fluorescence recovery after
photobleaching (FRAP). FRAP is used to measure the mobility of
fluorescently tagged molecules by bleaching these molecules and
recording how fast fluorescence intensity returns to the bleached
area. The diffusion rate of 10103 Mr fluorescein-dextran injected
into the plexus was found to be 51±7.6 m2/second (n=8) in the
absence of heart function (see Materials and methods). Fluorescence
recovery was significantly faster than diffusion in embryos with
normal circulation and we have used the term perfusion coefficient
to describe these measurements of flow. At the 3- to 4-somite stage,
perfusion coefficients ranged between 100 and 500 m2/second,
indicating the presence of slow, but significant, flow (Fig. 3). The
variability of plasma flow rates is not surprising given that the plexus
is an extensive network of highly branched vessels with varying
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Fig. 1. Time-lapse analysis of the initiation of erythroblast
circulation. Images were taken of a 6-somite mouse Tg(-globin-GFP)
embryo every 6 minutes for a total of 12.1 hours (see Movie 1 in the
supplementary material). The yolk sac (YS), heart (H) and somites (S) are
indicated. (A) Very few erythroblasts (arrow) are visible in the yolk sac
and embryo at the start of the movie (t=0). (B) The same field of view 1
hour later, indicating an increase in erythroblasts. Erythroblasts marked
with red arrows are not circulating. (C) Image taken 8.1 hours after the
start of the movie, showing more cells moving into the embryo and
beginning to fill the heart (H). (D) Fluorescent cells become more
evident in the heart towards the end of the time period by 11.7 hours
in culture. Clumps of erythroblasts are seen as some cells stop












resistance to flow. Perfusion values increased in later-stage embryos
(5- to 6-somite stage) and plasma flow in some regions was too fast
to measure (Fig. 3, indicated by asterisk with arrow). Thus, the heart
is a functional pump as soon as the myocardium begins to contract
and there is a significant period of plasma flow that precedes the
entry of erythroblasts into circulation.
Erythroblast circulation in Mlc2a–/– embryos
Mlc2a-null mice exhibit defects in atrial contraction, ventricle filling
and vascular remodeling (Huang et al., 2003), making this mutant
an excellent model to study the relationship between circulation and
remodeling. To visualize erythroblasts, Mlc2a mutant mice were
crossed with Tg(-globin-eGFP) mice and fluorescence images of
fixed Mlc2a–/–; Tg(-globin-eGFP) embryos confirmed that vascular
remodeling was impaired (Fig. 4). Mlc2a–/–; Tg(-globin-eGFP)
embryos were indistinguishable from littermates at 8.5 dpc.
However, 9.5 dpc Mlc2a–/– yolk sac vessels retained the
unremodeled capillary plexus, whereas Mlc2a+/+ and Mlc2a+/–
vessels were remodeled.
Although 8.5 dpc Mlc2a–/– embryos appear similar to littermates,
we hypothesized that altered flow patterns at 8.5 dpc could be
responsible for the lack of remodeling observed at 9.5 dpc. To
determine whether circulation is delayed in Mlc2a–/– embryos, we
compared the distribution of erythroblasts in Mlc2a mutant yolk sacs
with heterozygote or wild-type embryos (Table 1). By the 10-somite
stage, erythroblasts were routinely found throughout the plexus in
wild-type and heterozygous embryos, but were not seen consistently
throughout the whole yolk sac plexus until the 12- to 13-somite stage
in the Mlc2a–/– embryos. Thus, erythroblast circulation appeared to
be somewhat delayed in Mlc2a–/– embryos.
Next, we used time-lapse confocal microscopy to directly observe
blood cell movement in Mlc2a–/– embryos. A time-lapse sequence
of the initiation of flow in Mlc2a embryos showed that some
erythroblasts began to move, but then started to form clumps.
Eventually, the yolk sac filled with erythroblasts, but these cells were
not flowing freely (see Fig. S2 in the supplementary material). By
the 13-somite stage, normal embryos have well-established
circulation and pulsatile laminar-flow profiles are observed (Jones
et al., 2004). Time-lapse sequences from 13-somite Mlc2a–/–
embryos showed that forward flow of erythroblasts was impaired.
Erythroblasts were either stationary (data not shown) or moving in
an oscillatory pattern with an equal amount of retrograde and
anterograde motion (Fig. 5 and see Movie 2 in the supplementary
material). Thus, instead of the rapid, pulsatile laminar-flow patterns
seen in wild-type embryos, slow oscillatory flows were observed in
Mlc2a–/– embryos.
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Fig. 2. Initiation of plasma flow. 10103 Mr fluorescent dextran was
injected into the heart (Hrt) of early mouse embryos. The embryos were
incubated for 10 minutes and images were taken at 5 magnification.
The presence of fluorescence in the yolk sac after such a short
incubation was interpreted as the result of flowing blood plasma. In
most 2-somite embryos (5 out of 6 injected embryos), dextran remains
localized to the heart (A and B; arrow in B). In one case, however,
fluorescent dextran could be observed throughout the yolk sac (ys) (C
and D; arrow in D). Plasma circulation is consistently observed after the
3-somite stage (E, 3 somites; F, 6 somites). A and C are images taken
with brightfield illumination overlaid with fluorescence images of
fluorescein-dextran within the vessels (fluorescent microangiographs);
B,D,E and F are microangiographs.
Fig. 3. Perfusion coefficients of wild-type mouse embryos. Plasma
flow magnitude in the early capillary network was determined between
the 3- and 8-somite stages by calculating a perfusion coefficient using
FRAP. Each measurement is plotted and three measurements were
made from each embryo. The total number of embryos analyzed is
indicated for each stage. The upper range of perfusion coefficients
increases as cardiogenesis progresses and at the 6-somite stage and
later, flows that are too fast to measure are observed (asterisk and
arrow). We observed a range of values even within a given embryo











To determine how early the circulation is compromised, we
examined plasma flow in Mlc2a–/– embryos using FRAP. Perfusion
coefficients were comparable between wild-type (Fig. 3) and mutant
littermates at 3- to 6-somites (data not shown), but by 8- to 9-
somites, Mlc2a–/– embryos showed reduced plasma flow (Fig. 6). At
8- to 9-somites, we measured perfusion coefficients as high as 3835
m2/second in wild-type embryos (24 measurements in 8 embryos)
and often encountered regions with flow rates too fast to measure.
By contrast, perfusion coefficients in mutant embryos were nearly
four-fold lower (below 1045 m2/second; 27 measurements in 9
embryos) and no vessels exhibited flow outside the measurable
range. Of note, the perfusion coefficients measured in Mlc2a–/–
embryos were still larger than pure diffusion (51±21 m2/second),
indicating that plasma flow was present, but weaker than in wild-
type embryos. These data show that poor cardiac function can be
detected in very early mutant embryos, soon after the heart begins
to beat and before other phenotypes are evident.
Vascular remodeling requires fluid-derived force
Data from Mlc2a mutants show that both plasma and erythroblast
circulation are disrupted and are associated with impaired
remodeling, but these experiments do not explain why flow is
essential for remodeling. Since both plasma flow and erythroblast
movement were impaired, it was important to establish whether
proper plasma flow, which can carry soluble angiogenic factors, or
the circulation of erythroblasts, which affects mechanical force and
oxygen delivery, was essential. To distinguish between these
possibilities, we used polymerized acrylamide to prevent
erythroblasts from leaving the blood islands (see Materials and
methods) to determine whether blood with a lowered hematocrit,
and therefore a reduced apparent viscosity and oxygen delivery
capacity, was sufficient to induce normal remodeling.
In control and untreated embryos, a hierarchical vascular
branching pattern with enlarged avascular spaces was observed in
yolk sacs after 24 hours in culture (Fig. 7A-C). Erythroblasts were
robust in number and uniformly distributed within the vascular space
(Fig. 7C). When erythroblasts were prevented from leaving the
blood islands, vascular remodeling did not take place and the
immature plexus persisted (Fig. 7D-F). Turning was also impaired
in low-hematocrit embryos (Fig. 7D-F). To quantify these results,
we established a scoring system for the extent of remodeling and
turning (Table 2). These data confirm that reducing the hematocrit
had a significant impact on yolk sac size, embryo turning and vessel
remodeling. The methods used to reduce the hematocrit in embryos
had no effect on plasma flow. Plasma flow rates were comparable to
normal, untreated embryos (Fig. 8). Thus, we conclude that the
circulation of plasma alone is insufficient to drive vascular
remodeling, arguing against the idea that vascular remodeling is
triggered by a soluble factor distributed by blood flow.
The above experiments show that erythroblast circulation is
needed for remodeling. To determine if circulating erythroblasts
trigger remodeling by transporting oxygen or by increasing the
apparent viscosity of the circulating fluid (Chien et al., 1966), we
tested whether artificially increasing the viscosity of the
erythroblast-free plasma could restore remodeling. High-molecular-
weight synthetic sugars derived from plants, such as hetastarch,
increase the viscosity of solutions (Akers and Haidekker, 2004;
Haidekker et al., 2002). We injected a hetastarch solution into the
circulation of embryos with sequestered blood cells and these
embryos displayed clearly visible, large, branched yolk sac vessels
(Fig. 7G-I). These embryos were indistinguishable from wild type
in terms of the size of the yolk sac, and the embryo turning frequency
was restored (Table 2). Thus, increasing the viscosity was sufficient
to rescue the remodeling deficiency in low-hematocrit embryos. We
conclude that mechanical force, normally imparted by the flow of
circulating erythroblasts, is necessary and sufficient to induce vessel
remodeling in the yolk sac of early mouse embryos.
Expression of molecules involved in force
transduction
Fluid-derived forces can directly influence cell-signaling pathways
in endothelial cells (see Li et al., 2005). PECAM-1 and VE-cadherin
(also known as Pecam1 and cadherin 5, respectively – Mouse
Genome Informatics) are part of a complex that can act as a
mechanotransducer of shear stress (Tzima et al., 2005). Also, shear
stress increases the levels of the mRNA encoding nitric oxide
synthase 3 (eNOS; also known as Nos3 – Mouse Genome
Informatics) (Topper et al., 1996) and induces changes in the
subcellular localization of eNOS protein through a PECAM-1-
activated pathway (Cheng et al., 2005; Dusserre et al., 2004;
Fleming et al., 2005). To determine whether these molecules play a
role in force-related signaling in embryonic vessels, we examined
the expression of PECAM-1, VE-cadherin and eNOS in control,
low-hematocrit and low-hematocrit+hetastarch embryos. PECAM-
1 (Fig. 9A-E) was observed on endothelial and erythroblast cell
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Fig. 4. Phenotype of Mlc2a–/– mouse embryos. Heterozygous
(A,C,E) and knockout (B,D,F) littermates at the 7-somite (A,B), 10-
somite (C,D) and 23-somite (9.5 dpc) (E,F) stage. The capillary plexus is
demarcated by GFP-expressing erythroblasts. At the 7-somite stage,
blood islands have clearly formed in both wild-type (A) and Mlc2a-null
(B) embryos and erythroblasts begin to circulate in both wild-type (C)
and Mlc2a mutant (D) embryos. However, the plexus retains an
immature phenotype and fails to remodel by embryonic day 9.5 in the












membranes in both large (Fig. 9A) and small (Fig. 9B) vessels in
control embryos. PECAM-1 staining appeared somewhat reduced,
but was still found on the surface of endothelial cells of unremodeled
vessels of the low-hematocrit yolk sacs (Fig. 9C). Since large vessels
were not observed in the low-hematocrit vessels, only small vessels
are shown. Robust PECAM-1 staining was observed on the
endothelial cell membrane in both large (Fig. 9D) and small vessels
(Fig. 9E) when plasma viscosity was restored. VE-cadherin
expression was also localized to the membrane of yolk sac
endothelial cells and staining appeared similar in all yolk sacs,
indicating that the levels of VE-cadherin protein are not dependent
on fluid force (Fig. 9F-J). In control vessels, eNOS protein was
found localized to the perinuclear region as well as the cell
membrane as has been described (Cheng et al., 2005). eNOS was
barely detected above background in low-hematocrit embryos and
localization of eNOS to membrane or perinuclear regions was not
observed. eNOS expression was restored in low-hematocrit+
hetastarch embryos and membrane staining was evident on large
remodeled vessels, consistent with previous findings that increased
shear stress stimulates translocation of intracellular eNOS to the cell
membrane (Cheng et al., 2005). Further, cell membrane proteins
highlight the physical changes of endothelial cells in response to
changes in mechanical force. Endothelial cells exposed to shear
stress are known to elongate in the direction of the flow (Dewey et
al., 1981), and elongated cells are evident in large vessels in Fig. 9.
Endothelial cells in low-hematocrit vessels had a more cuboidal
shape, but remained intact and retained cell-cell associations. These
results show that eNOS levels are sensitive to changes in
hemodynamic force during remodeling in the yolk sac and that
mechanosensory signaling pathways identified in vitro also appear
to regulate force responses in vivo during development
DISCUSSION
The main goal of these studies was to investigate the role of blood
circulation in vessel remodeling during embryonic development.
Studies of the initiation of circulation in wild-type embryos and in
mutants with impaired cardiac contractility led us to hypothesize that
the increase in apparent viscosity occurring when blood cells enter
the circulation results in a physical stimulus that triggers remodeling.
We tested this hypothesis by preventing blood cells from entering
circulation, thereby reducing blood viscosity, and showed that
erythroblast circulation was required for remodeling and for the
proper expression of force-regulated factors. Since remodeling and
the expression of force-related factors could be rescued in low-
hematocrit embryos with the addition of hetastarch, we conclude
that changes in the viscosity of blood, which alters the physical force
exerted by the blood, are sufficient to induce vascular remodeling
and to trigger signaling cascades within endothelial cells in the
embryonic mouse yolk sac.
In the course of these studies, we have established a new, sensitive
approach for detecting changes in early plasma circulation using
FRAP. Our data show that there is plasma circulation between the
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Table 1. Location of erythroblasts in the vascular plexus: comparison between wild-type/heterozygous and Mlc2a–/– embryos  
Somite stage 
Location 4 5 6 7 8 9 10 11 12 13 14-15 
Mlc2a+/+ and Mlc2a+/– 
Blood islands (%)   67 50 37 14        
Partial plexus (%) 33 50 56 68 58 52 22     
Full plexus (%)   7 18 42 48 78 100 100 100 100 
Total (n) 12 22 27 28 24 25 18 12 11 12 17 
Mlc2a–/– 
Blood islands (%)  86 100 33 71 14  25     
Partial plexus (%) 14  67 29 86 67 75 100   33 
Full plexus (%)      33    100 66 
Total (n) 7 4 6 7 7 6 4 4  5 3 
Embryos were harvested at 8.5 dpc and were separated by somite stage. Yolk sac erythroblast location was scored as localized to the blood islands only, to the 
blood islands and the proximal vascular plexus, or observed throughout the blood island area and the entire vascular plexus. Shaded entries denote locations where 
the highest percentage of erythroblasts was observed.
Fig. 5. Erythroblast motion
in Mlc2a–/– mouse embryos.
The motion of erythroblasts
(green) within vessels of
Mlc2a–/– embryos was imaged
at two frames/second. Images
were taken at (A) 0, (B) 2.5, (C)
5, (D) 7.5, (E) 10, (F) 12.5 and
(G) 15 seconds. The motion of
individual erythroblasts,
marked by colored dots in A-G,
were tracked and these tracks
are shown (H), illustrating that
erythroblasts oscillate with as












embryo and yolk sac by the 2- to 3-somite stage, indicating that
patent vessels in the yolk sac are formed by the time the heart starts
to beat. This extends previous findings describing a patent heart tube
by the 6-somite stage (see Ji et al., 2003). Further, defects in
embryonic circulation in Mlc2a mutants could be detected by FRAP
before an obvious phenotype was discernable and before the steady
flow of erythroblasts is present. Thus, this method is effective in
detecting defects in cardiac contraction prior to the onset of
remodeling and can be helpful in determining whether remodeling
defects are the secondary consequence of impaired heart function.
Analysis of Mlc2a embryos indicated that erythroblast circulation
was delayed. Without the benefit of time-lapse analysis, one might
conclude that there was only a minor flow abnormality, but time-
lapse data revealed that flow was severely disturbed. The slow
oscillatory flow in Mlc2a mutants is sufficient to distribute blood
cells from the blood islands into more-proximal regions of the
plexus, but insufficient to induce remodeling. Previous work has
shown that oscillatory patterns of flow can enhance cell proliferation
(Chiu et al., 1998; Davies et al., 1986; Levesque et al., 1990), but the
number of proliferating cells in the yolk sac is similar in Mlc2a
mutant and wild-type embryos (data not shown). Also, culturing
mouse embryos in KB-R7943, an Ncx1 inhibitor, results in impaired
remodeling, but does not induce oscillations (our unpublished data).
Thus, the remodeling defect in Mlc2a mutant embryos is likely to be
due to reduced laminar flow, rather than to the presence of abnormal
oscillatory flow.
Time-lapse confocal microscopy of live embryos with GFP-
labeled erythroblasts shows that erythroblasts move intermittently
in the circulation by the 6- to 7-somite stage, in agreement with
previous reports (Ji et al., 2003; McGrath et al., 2003; Phoon et al.,
2000; Phoon et al., 2002). By physically blocking erythroblasts from
leaving the blood islands, we have been able to conclude that the
onset of erythroblast circulation causes a change in viscosity, which
is necessary for vessel remodeling. This role for primitive
erythroblasts has not yet been described because many mutations
that lead to a reduction in primitive erythroblasts also affect
endothelial cells directly (Oike et al., 1999; Oshima et al., 1996;
Robb et al., 1995; Shalaby et al., 1995; Shivdasani et al., 1995; Suri
et al., 1996; Visvader et al., 1998). It is assumed in many of these
cases that disruption of the endothelial cell program is the direct
cause of the remodeling defect. We would argue that any significant
reduction in primitive erythroblasts alone could account for the
remodeling phenotype, but presently there is no way to eliminate the
erythroblast population exclusively.
In addition to affecting vessel remodeling, reducing the
hematocrit also resulted in impaired embryonic turning. Although it
is not entirely clear why this occurs, yolk sacs of embryos with
sequestered erythroblasts are slightly smaller than control embryos
(Table 2). It is possible that poor circulation reduces the tension
within the yolk sac or the embryo proper leading to impaired turning.
Delays in turning were also observed in Mlc2a-deficient embryos
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Fig. 6. Perfusion coefficients in wild-type and Mlc2a–/– mouse
embryos. FRAP was used to measure perfusion coefficients within the
early embryonic blood vessels in Mlc2a–/– and wild-type embryos at the
8- to 9-somite stage. Each measurement is plotted and three
measurements were made from each embryo. The total number of
embryos analyzed is indicated for each genotype. For reproducibility,
measurements were always taken on the arterial side of the yolk sac
near the caudal end of the embryo. Perfusion coefficient ranges were
significantly lower in mutant than in wild-type embryos. In wild-type
embryos, some perfusion coefficients were too fast to measure using
FRAP (asterisk and arrow). By contrast, perfusion coefficients could
always be measured in mutant embryos. Perfusion coefficients up to
3835 m2/second were found in wild-type embryos, whereas the
maximum perfusion rate seen in Mlc2a mutant embryos was 1045
m2/second.
Fig. 7. Plasma viscosity alters yolk sac remodeling. Control, low-
hematocrit and low-hematocrit+hetastarch mouse embryos were
prepared as described (see Materials and methods). Brightfield images
show that control embryos turned (A) and yolk sac vessels remodeled
into a hierarchical, branched phenotype as evident from Texas Red (TR)-
dextran microangiograms (B). eGFP expression (green) from the Tg(-
globin-GFP) construct shows that erythroblasts are evident in all parts of
the yolk sac vasculature (C). The embryo shown in A-C was given a
score of 5 for both turning and remodeling. Embryos with sequestered
erythroblasts often did not turn but continued to develop after 24
hours in culture (D). The yolk sac vasculature did not remodel and
retained features of an immature plexus (E). Erythroblasts remained
confined to the blood islands (F). This embryo was scored a 1 for both
turning and remodeling. Embryo turning was restored (score=5) (G)
and yolk sac remodeling was rescued (score=5) (H) in embryos with
sequestered erythroblasts (I) after injection of the hetastarch solution.












(data not shown); however, we cannot assess whether this is a
common feature of mice with hemodynamic deficiencies as it is
generally not reported.
Work in both zebrafish (Isogai et al., 2003) and chick (le Noble et
al., 2004) has shown that blood flow is required for the dynamic
remodeling of interconnections between vessels, but is not required
for vasculogenesis. Similarly, our data show that yolk sac vessels are
formed and can support flow by the time the heart begins to beat, but
mature vessels do not develop if viscous flow is not established.
Consistent with this, endothelial cells are found lining the yolk sac
plexus by the time the heart begins to beat (Ferkowicz et al., 2003;
Fraser et al., 2005). Thus, it is clear that blood flow is not required
for the differentiation of endothelial cells.
Our work shows that the mechanical force exerted by blood flow
imparts an important signal to trigger vascular remodeling. Precisely
which forces are most important for vascular remodeling remains an
open question, because both shear stress and circumferential strain
could be instructive. Shear stress is directly dependant on the
apparent viscosity of the fluid and is likely to be the critical force
acting on early endothelial cells during vascular remodeling in the
mouse embryo. Shear stress has been shown to induce changes in
gene expression, cytoskeletal architecture and proliferation in
cultured endothelial cells (Li et al., 2005) and our previous work has
shown that shear stress in early mouse circulation is well within the
range known to induce these types of changes (Jones et al., 2004).
Despite our evidence supporting a role for shear stress, we cannot
state that shear stress is the only essential force at work in this system
because circumferential strain also contributes to forces felt by
endothelial cells, and we cannot distinguish a separate role for these
types of forces during embryogenesis.
Recently, there have been great strides in identifying the
molecular components of a shear stress transduction pathway,
implicating many molecules that are expressed during
vasculogenesis and vessel remodeling (Garcia-Cardena et al.,
2001; Li et al., 2005). Shear stress is thought to be sensed by a
functional complex of PECAM-1, VE-cadherin and Vegfr2 (also
known as Flk1 and Kdr – Mouse Genome Informatics) which,
when activated, in turn activates eNOS, PI3k (Pik3r1), chicken
Src and the conversion of integrins to high-affinity forms
(Fleming et al., 2005; Orr et al., 2006; Topper et al., 1996; Tzima
et al., 2005). Mutant analysis has gleaned only limited
information about the mechanisms of force transduction in
embryonic vessel remodeling. Surprisingly, PECAM-1-knockout
mice on two different background strains are viable to adulthood
(Duncan et al., 1999; Schenkel et al., 2006). Vegfr2 plays a role
in the early differentiation of mesodermal lineages (Shalaby et al.,
1997; Shalaby et al., 1995) making it difficult to assess later roles.
VE-cadherin-deficient embryos fail to remodel the initial vascular
plexus (Carmeliet et al., 1999; Gory-Faure et al., 1999), which
would be predicted if endothelial cells could not properly sense
shear stress; however, endothelial cells become detached and
undergo apoptosis, which might be the primary defect (Carmeliet
et al., 1999). Septal defects, deficiencies in cardiac maturation and
function, vascular dysfunction, reduced angiogenesis and
increased mortality are hallmarks of neonatal mice deficient in
eNOS (Feng et al., 2002; Lepic et al., 2006; Zhao et al., 2002),
despite the fact that these mice can survive to adulthood and
reproduce. Thus, the involvement of these factors in
mechanotransduction in the embryo has been difficult to define
through mutant analysis. Our data show that eNOS is regulated by
hemodynamic force in embryos, as would be predicted by
experiments showing that mRNA levels and the subcellular
localization of eNOS are regulated by shear stress in vitro (Cheng
et al., 2005; Dekker et al., 2005; Dusserre et al., 2004; Fleming et
al., 2005; Topper et al., 1996). Also, PECAM-1 and VE-cadherin
persist on the cell surface in low-hematocrit embryos, showing
that endothelial cells remain intact and continue to express
molecules thought to be required for force activation. Continued
expression of these proteins would be expected because low-
hematocrit embryos can be rescued by restoring hemodynamic
force. Overall, our data show that the mechanosensory signaling
pathways identified in cultured cells also appear to be functional
in vivo during development.
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Table 2. Quantitative analysis of growth, embryo turning and yolk sac vessel remodeling in control and treated embryos
Treatment n Yolk sac (mm2) Turn score Remodel score
Untreated control 23 5.23±0.19 3.78±0.32 4.13±0.30
Low hematocrit 41 4.06±0.12* 1.70±0.15* 1.76±0.16* 
Low hematocrit+hetastarch 19 5.19±0.28 2.68±0.32 3.58±0.30
Acrylamide only 5 4.93±0.41 3.80±0.49 4.20±0.49
TEMED only 14 5.93±0.28 4.00±0.36 4.64±0.20
Hetastarch only 12 6.05±0.24 3.50±0.44 4.25±0.37
After 24 hours in roller culture, embryos were individually imaged. The size of the yolk sac is the area of the traced image, and the embryo was assigned a score for degree of
turning and degree of remodeling (see Materials and methods). A score of 1 describes an unturned embryo or unremodeled yolk sac, and a score of 5 describes a normally
turned embryo and normally remodeled yolk sac.
*Significant difference (P<0.05) from control value.
Fig. 8. Perfusion coefficients in low-hematocrit mouse embryos.
To ensure that plexus plasma flow was not hampered by immobilizing
the erythroblasts to the yolk sac, we determined the perfusion
coefficient range in wild-type and acrylamide-treated embryos at 8- to
9-somites. Each measurement is plotted and three measurements were
made from each embryo. The total number of embryos analyzed is
indicated for each treatment. A similar range of measurements is seen
in control and acrylamide-treated embryos indicating that plasma flow












In this study, we have used novel methods to define a role for fluid-
derived mechanical signaling during embryonic development. By
generating methods to manipulate the physical properties of the
early blood, we have been able to show that force activation of
embryonic endothelial cells is required for normal vascular
remodeling. Strategies such as these illustrate the strength of
combining genetic and physiological methods to understand
complex cardiovascular phenotypes, and open the door to further
investigation of mechanical signaling in vivo.
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